surgery-anesthesia-euro-gastro-congress-2018-tracks

Page 39

Note:

N o v e m b e r 1 2 - 1 3 , 2 0 1 8 | R o m e , I t a l y

Joint Event on

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

Surgery and Anesthesia 2018 & Euro Gastro Congress 2018

Case Reports in Surgery and Invasive Procedures

Volume 2

GASTROENTEROLOGY

International Conference on

SURGERY AND ANESTHESIA

International Conference on

Fernando Robledo, Case Rep Surg Invasive Proced 2018, Volume 2

INITIAL EXPERIENCE WITH INTRAGASTRIC

BALLOON LEXBAL

IN THE TREATMENT

OF PATIENTS WITH MILD TO MODERATE

OBESITY (TYPE I-II)

Fernando Robledo

Maryland-in-Buenos Aires, Argentina

o evaluate the effectiveness and response Gastric balloon (Lexbal) in the

treatment of mild to moderate obesity

Methods:

We conducted in one clinic and hospital paroissien an observation-

al, retrospective study. We have compiled the results of 12 follow intragas-

tric balloons (Balon Lexbal ) in obese patients with mild to moderate type

I-II (BMI between 28 and 34.9kg/m2 ) placed in 2012 and 2015 losses have

been achieved over 70% of excess weight . Furthermore, it has been observed

satisfaction of our patients

Measurements:

Descriptive observational study in which the sample is made

up of the 12 patients treated with balloon LEXBAL in our midst. The variables

studied were age, sex, weight, BMI, percentage of weight lost, fill volume, tol-

erance, satisfaction and dietary monitoring by patients

Results:

Over 80% degree of patient satisfaction, 70% decrease in weight

above the average ( over 12 kilos ) better response in those presenting adher-

ence to nutritional treatment and no differences were observed in the volume

of filling the balloon.

Conclusions:

Treatment with intragastric balloon, along with a nutritional

monitoring allows us to re-educate the patient, and change their eating hab-

its. Just for gradual diet, and to adapt each phase as tolerated by the patient,

helps us to improve dietary behavior and facilitates greater weight loss. The

intragastric balloon is a safe, well tolerated, with few adverse effects and rel-

atively simple in the hands accustomed to endoscopic practice. We believe it

can be considered an effective adjunctive therapy in selected cases of mild /

moderate obesity.

Fernando Robledo is currently working at Maryland in

Buenos Aires, Argentina.

frobledo@intramed.net

BIOGRAPHY